Literature DB >> 24469446

Periostin induces intracellular cross-talk between kinases and hyaluronan in atrioventricular valvulogenesis.

Shibnath Ghatak1, Suniti Misra, Russell A Norris, Ricardo A Moreno-Rodriguez, Stanley Hoffman, Robert A Levine, Vincent C Hascall, Roger R Markwald.   

Abstract

Periostin (PN), a novel fasciclin-related matricellular protein, has been implicated in cardiac development and postnatal remodeling, but the mechanism remains unknown. We examined the role of PN in mediating intracellular kinase activation for atrioventricular valve morphogenesis using well defined explant cultures, gene transfection systems, and Western blotting. The results show that valve progenitor (cushion) cells secrete PN into the extracellular matrix, where it can bind to INTEGRINs and activate INTEGRIN/focal adhesion kinase signaling pathways and downstream kinases, PI3K/AKT and ERK. Functional assays with prevalvular progenitor cells showed that activating these signaling pathways promoted adhesion, migration, and anti-apoptosis. Through activation of PI3K/ERK, PN directly enhanced collagen expression. Comparing PN-null to WT mice also revealed that expression of hyaluronan (HA) and activation of hyaluronan synthase-2 (Has2) are also enhanced upon PN/INTEGRIN/focal adhesion kinase-mediated activation of PI3K and/or ERK, an effect confirmed by the reduction of HA synthase-2 in PN-null mice. We also identified in valve progenitor cells a potential autocrine signaling feedback loop between PN and HA through PI3K and/or ERK. Finally, in a three-dimensional assay to simulate normal valve maturation in vitro, PN promoted collagen compaction in a kinase-dependent fashion. In summary, this study provides the first direct evidence that PN can act to stimulate a valvulogenic signaling pathway.

Entities:  

Keywords:  Atrioventricular Valve; Cd44; Cell Adhesion; Cell Migration; Collagen; Hyaluronate; Integrins; Intracellular Kinase Signaling; Periostin; Prevalvular Cushion Cells

Mesh:

Substances:

Year:  2014        PMID: 24469446      PMCID: PMC3961678          DOI: 10.1074/jbc.M113.539882

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

1.  Hyaluronan minireview series.

Authors:  John McDonald; Vincent C Hascall
Journal:  J Biol Chem       Date:  2001-11-20       Impact factor: 5.157

2.  Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme.

Authors:  T D Camenisch; A P Spicer; T Brehm-Gibson; J Biesterfeldt; M L Augustine; A Calabro; S Kubalak; S E Klewer; J A McDonald
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Long form of latent TGF-β binding protein 1 (Ltbp1L) regulates cardiac valve development.

Authors:  Vesna Todorovic; Erin Finnegan; Laina Freyer; Lior Zilberberg; Mitsuhiko Ota; Daniel B Rifkin
Journal:  Dev Dyn       Date:  2011-01       Impact factor: 3.780

Review 4.  Cell biology of cardiac cushion development.

Authors:  Anthony D Person; Scott E Klewer; Raymond B Runyan
Journal:  Int Rev Cytol       Date:  2005

5.  Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

Authors:  Kim Midwood; Sandra Sacre; Anna M Piccinini; Julia Inglis; Annette Trebaul; Emma Chan; Stefan Drexler; Nidhi Sofat; Masahide Kashiwagi; Gertraud Orend; Fionula Brennan; Brian Foxwell
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

6.  Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor.

Authors:  Shibnath Ghatak; Vincent C Hascall; Roger R Markwald; Suniti Misra
Journal:  J Biol Chem       Date:  2010-03-03       Impact factor: 5.157

Review 7.  Molecular regulation of atrioventricular valvuloseptal morphogenesis.

Authors:  L M Eisenberg; R R Markwald
Journal:  Circ Res       Date:  1995-07       Impact factor: 17.367

8.  Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells.

Authors:  Shibnath Ghatak; Suniti Misra; Bryan P Toole
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

9.  Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway.

Authors:  Shibnath Ghatak; Suniti Misra; Bryan P Toole
Journal:  J Biol Chem       Date:  2002-07-26       Impact factor: 5.157

10.  Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE.

Authors:  Suniti Misra; Vincent C Hascall; Carla De Giovanni; Roger R Markwald; Shibnath Ghatak
Journal:  J Biol Chem       Date:  2009-02-26       Impact factor: 5.157

View more
  29 in total

1.  Cadherin-11 coordinates cellular migration and extracellular matrix remodeling during aortic valve maturation.

Authors:  Caitlin J Bowen; Jingjing Zhou; Derek C Sung; Jonathan T Butcher
Journal:  Dev Biol       Date:  2015-07-16       Impact factor: 3.582

Review 2.  Discoidin domain receptor-1 and periostin: new players in chronic kidney disease.

Authors:  Carlo Alfieri; Panagiotis Kavvadas; Paola Simonini; Masami Ikehata; Jean Claude Dussaule; Christos E Chadjichristos; Maria Pia Rastaldi; Piergiorgio Messa; Christos Chatziantoniou
Journal:  Nephrol Dial Transplant       Date:  2015-03-31       Impact factor: 5.992

3.  Periostin Promotes Cell Proliferation and Macrophage Polarization to Drive Repair after AKI.

Authors:  Raphaёl Kormann; Panagiotis Kavvadas; Sandrine Placier; Sophie Vandermeersch; Aude Dorison; Jean-Claude Dussaule; Christos E Chadjichristos; Niki Prakoura; Christos Chatziantoniou
Journal:  J Am Soc Nephrol       Date:  2019-11-05       Impact factor: 10.121

4.  Effect of Teriparatide Treatment on Circulating Periostin and Its Relationship to Regulators of Bone Formation and BMD in Postmenopausal Women With Osteoporosis.

Authors:  Fatma Gossiel; Jessica R Scott; Margaret A Paggiosi; Kim E Naylor; Eugene V McCloskey; Nicola F A Peel; Jennifer S Walsh; Richard Eastell
Journal:  J Clin Endocrinol Metab       Date:  2018-04-01       Impact factor: 5.958

5.  Phosphoinositide 3-kinase/protein kinase B/periostin mediated platelet-derived growth factor-induced cell proliferation and extracellular matrix production in lupus nephritis.

Authors:  Xue Zhao; Jun Hao; Huijun Duan; Zanhua Rong; Fan Li
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

6.  Knockout of hyaluronan synthase 1, but not 3, impairs formation of the retrocalcaneal bursa.

Authors:  Katie J Sikes; Kristen Renner; Jun Li; K Jane Grande-Allen; Jennifer P Connell; Valbona Cali; Ronald J Midura; John D Sandy; Anna Plaas; Vincent M Wang
Journal:  J Orthop Res       Date:  2018-07-13       Impact factor: 3.494

7.  Filamin-A as a Balance between Erk/Smad Activities During Cardiac Valve Development.

Authors:  Katelynn Toomer; Kimberly Sauls; Diana Fulmer; Lilong Guo; Kelsey Moore; Janiece Glover; Rebecca Stairley; Joyce Bischoff; Robert A Levine; Russell A Norris
Journal:  Anat Rec (Hoboken)       Date:  2018-10-05       Impact factor: 2.064

Review 8.  Periostin and TGF-β-induced protein: Two peas in a pod?

Authors:  Deane F Mosher; Mats W Johansson; Mary E Gillis; Douglas S Annis
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-08-10       Impact factor: 8.250

9.  Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancer.

Authors:  Suniti Misra; Shibnath Ghatak; Alok Vyas; Paul O'Brien; Roger R Markwald; Madhukar Khetmalas; Vincent C Hascall; James B McCarthy; Nikos K Karamanos; Markku I Tammi; Raija H Tammi; Glenn D Prestwitch; Subhash Padhye
Journal:  Med Chem Res       Date:  2014-08-01       Impact factor: 1.965

Review 10.  Periostin and its interacting proteins in the construction of extracellular architectures.

Authors:  Isao Kii; Harumi Ito
Journal:  Cell Mol Life Sci       Date:  2017-09-08       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.